Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

An 11-year-old girl with severe hair loss regrew and repigmented her hair after JAK inhibitor treatment.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Personalized homeopathic treatment may help manage alopecia areata.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Hominis Placenta Pharmacopunture helped regrow hair in a patient with stress-induced hair loss.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Upadacitinib may cause hair loss.

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Hair follicle-derived sheets can effectively treat vitiligo by repigmenting skin.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Krill oil may help reduce prostate enlargement and growth.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Electrospun scaffolds can improve healing in diabetic wounds.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Effective PCOS treatments require targeting specific signaling pathways.